dna binding 1 Search Results


id1  (Proteintech)
93
Proteintech id1
Noggin antagonize BMP's inhibition of myogenic differentiation of DPSCs. (a) 3D protein structure of Noggin's competitive inhibition of BMP4 binding to BMPRIA. Red indicates Noggin. Gray indicates BMP4. Purple indicates BMPRIA. Cyan indicates a competitive site of Noggin binding to BMPRIA. (b) Protein expression of Pax7, Pax3, Eya2, and Desmin was assessed using a western blot when rescuing with BMP4. (c–e) Protein expression of p-Smad1/5/9 and Smad1 was assessed using western blot by Noggin treatment for different times (3, 6, and 9 h) and subsequently stimulated with BMP4 or control for 1 h (c), and semiquantitative analysis of the expression ratio of (d) p-Smad1/5/9/ β -actin, (e) p-Smad1/5/9/Smad1 were performed ( n = 4). (f, g) Relative mRNAs expression of (f) <t>ID1</t> and (g) MSX1 were assessed using quantitative PCR ( n = 3). The differences were presented as ⁣ ∗ p < 0.05 and ⁣ ∗∗∗ p < 0.001. 100N = 100 ng/mL Noggin; 200N = 200 ng/mL Noggin. BMP, bone morphogenetic protein; BMPRIA, BMP4 to BMP-receptor I A; DPSCs, dental pulp stem cells; PCR, polymerase chain reaction.
Id1, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dna+binding+1/ID1+Antibody/pmc11699990-70-58-64
Average 93 stars, based on 1 article reviews
id1 - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier
antibody immunogen (dna vaccination) binding1 monoclonal mab36  (ImmunoGen Inc)
90
ImmunoGen Inc antibody immunogen (dna vaccination) binding1 monoclonal mab36
Noggin antagonize BMP's inhibition of myogenic differentiation of DPSCs. (a) 3D protein structure of Noggin's competitive inhibition of BMP4 binding to BMPRIA. Red indicates Noggin. Gray indicates BMP4. Purple indicates BMPRIA. Cyan indicates a competitive site of Noggin binding to BMPRIA. (b) Protein expression of Pax7, Pax3, Eya2, and Desmin was assessed using a western blot when rescuing with BMP4. (c–e) Protein expression of p-Smad1/5/9 and Smad1 was assessed using western blot by Noggin treatment for different times (3, 6, and 9 h) and subsequently stimulated with BMP4 or control for 1 h (c), and semiquantitative analysis of the expression ratio of (d) p-Smad1/5/9/ β -actin, (e) p-Smad1/5/9/Smad1 were performed ( n = 4). (f, g) Relative mRNAs expression of (f) <t>ID1</t> and (g) MSX1 were assessed using quantitative PCR ( n = 3). The differences were presented as ⁣ ∗ p < 0.05 and ⁣ ∗∗∗ p < 0.001. 100N = 100 ng/mL Noggin; 200N = 200 ng/mL Noggin. BMP, bone morphogenetic protein; BMPRIA, BMP4 to BMP-receptor I A; DPSCs, dental pulp stem cells; PCR, polymerase chain reaction.
Antibody Immunogen (Dna Vaccination) Binding1 Monoclonal Mab36, supplied by ImmunoGen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dna+binding+1/antibody+immunogen++dna+vaccination++binding1+monoclonal+mab36/pmc06911215__pnas__1912503116__sapp-4-0-1
Average 90 stars, based on 1 article reviews
antibody immunogen (dna vaccination) binding1 monoclonal mab36 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
id1 antibody  (Boster Bio)
90
Boster Bio id1 antibody
Noggin antagonize BMP's inhibition of myogenic differentiation of DPSCs. (a) 3D protein structure of Noggin's competitive inhibition of BMP4 binding to BMPRIA. Red indicates Noggin. Gray indicates BMP4. Purple indicates BMPRIA. Cyan indicates a competitive site of Noggin binding to BMPRIA. (b) Protein expression of Pax7, Pax3, Eya2, and Desmin was assessed using a western blot when rescuing with BMP4. (c–e) Protein expression of p-Smad1/5/9 and Smad1 was assessed using western blot by Noggin treatment for different times (3, 6, and 9 h) and subsequently stimulated with BMP4 or control for 1 h (c), and semiquantitative analysis of the expression ratio of (d) p-Smad1/5/9/ β -actin, (e) p-Smad1/5/9/Smad1 were performed ( n = 4). (f, g) Relative mRNAs expression of (f) <t>ID1</t> and (g) MSX1 were assessed using quantitative PCR ( n = 3). The differences were presented as ⁣ ∗ p < 0.05 and ⁣ ∗∗∗ p < 0.001. 100N = 100 ng/mL Noggin; 200N = 200 ng/mL Noggin. BMP, bone morphogenetic protein; BMPRIA, BMP4 to BMP-receptor I A; DPSCs, dental pulp stem cells; PCR, polymerase chain reaction.
Id1 Antibody, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dna+binding+1/Anti-ID1+Antibody/pm20970407-147-74-79
Average 90 stars, based on 1 article reviews
id1 antibody - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
id1 of dna binding 1 antibody  (biorbyt)
N/A
Rabbit Polyclonal to Id1 of DNA binding 1. Isotype Note: IgG Host Note: Rabbit Conjugation Note: Unconjugated Reactivity Note: Human, Mouse, Rat Application Note: WB, IHC-P, P-ELISA
   Buy from Supplier
inhibitor of dna binding 1 human recombinant  (Angio-Proteomie)
N/A
ID1 Human Recombinant produced in E. coli is a single polypeptide chain containing 178 amino acids (1-155) and having a molecular mass of 18.5kDa. ID1 is fused to a 23 amino acid His-tag at N-terminus
   Buy from Supplier
id1 of dna binding 1 antibody (fitc)  (biorbyt)
N/A
Rabbit Polyclonal to Id1 of DNA binding 1 conjugated to FITC. Isotype Note: IgG Host Note: Rabbit Conjugation Note: FITC Reactivity Note: Human, Mouse, Rat Application Note: IF/ICC
   Buy from Supplier
recombinant human inhibitor of dna binding 1, dominant negative helix-loop-helix protein, his-tagged  (Creative BioMart)
N/A
ID1, 1-155aa, Human, His tag, E.coliID1 is a helix-loop-helix (HLH) protein that can form heterodimers with members of the basic HLH family of transcription factors. The protein has no DNA binding activity and therefore can
   Buy from Supplier
inhibitor of dna binding 1, human recombinant  (RayBiotech)
N/A
Inhibitor of DNA Binding 1, Human Recombinant; 10 ug
   Buy from Supplier

Image Search Results


Noggin antagonize BMP's inhibition of myogenic differentiation of DPSCs. (a) 3D protein structure of Noggin's competitive inhibition of BMP4 binding to BMPRIA. Red indicates Noggin. Gray indicates BMP4. Purple indicates BMPRIA. Cyan indicates a competitive site of Noggin binding to BMPRIA. (b) Protein expression of Pax7, Pax3, Eya2, and Desmin was assessed using a western blot when rescuing with BMP4. (c–e) Protein expression of p-Smad1/5/9 and Smad1 was assessed using western blot by Noggin treatment for different times (3, 6, and 9 h) and subsequently stimulated with BMP4 or control for 1 h (c), and semiquantitative analysis of the expression ratio of (d) p-Smad1/5/9/ β -actin, (e) p-Smad1/5/9/Smad1 were performed ( n = 4). (f, g) Relative mRNAs expression of (f) ID1 and (g) MSX1 were assessed using quantitative PCR ( n = 3). The differences were presented as ⁣ ∗ p < 0.05 and ⁣ ∗∗∗ p < 0.001. 100N = 100 ng/mL Noggin; 200N = 200 ng/mL Noggin. BMP, bone morphogenetic protein; BMPRIA, BMP4 to BMP-receptor I A; DPSCs, dental pulp stem cells; PCR, polymerase chain reaction.

Journal: Stem Cells International

Article Title: Noggin Combined With Human Dental Pulp Stem Cells to Promote Skeletal Muscle Regeneration

doi: 10.1155/sci/2812390

Figure Lengend Snippet: Noggin antagonize BMP's inhibition of myogenic differentiation of DPSCs. (a) 3D protein structure of Noggin's competitive inhibition of BMP4 binding to BMPRIA. Red indicates Noggin. Gray indicates BMP4. Purple indicates BMPRIA. Cyan indicates a competitive site of Noggin binding to BMPRIA. (b) Protein expression of Pax7, Pax3, Eya2, and Desmin was assessed using a western blot when rescuing with BMP4. (c–e) Protein expression of p-Smad1/5/9 and Smad1 was assessed using western blot by Noggin treatment for different times (3, 6, and 9 h) and subsequently stimulated with BMP4 or control for 1 h (c), and semiquantitative analysis of the expression ratio of (d) p-Smad1/5/9/ β -actin, (e) p-Smad1/5/9/Smad1 were performed ( n = 4). (f, g) Relative mRNAs expression of (f) ID1 and (g) MSX1 were assessed using quantitative PCR ( n = 3). The differences were presented as ⁣ ∗ p < 0.05 and ⁣ ∗∗∗ p < 0.001. 100N = 100 ng/mL Noggin; 200N = 200 ng/mL Noggin. BMP, bone morphogenetic protein; BMPRIA, BMP4 to BMP-receptor I A; DPSCs, dental pulp stem cells; PCR, polymerase chain reaction.

Article Snippet: Antibodies against β -actin (abs830031; Absin Bioscience, Shanghai, China), Pax7 (ab187339), and Myf5 (ab125078) from Abcam; MyHC IIB (BF-F3) and MyHC IIA (SC-71) from Developmental Studies Hybridoma Bank (DSHB, ID, USA); p-Smad 1/5/9 (#13820) and Smad 1 (#6944) from Cell Signaling Technology (CST, MA, USA); and MyoD (#18943), Desmin (#60226), MRF4 (#11754), Pax3 (#21383), Six1 (#10709), Eya2 (#11314), ID1 (#18475), and MSX1 (#17678) from Proteintech (IL, USA) were used.

Techniques: Inhibition, Binding Assay, Expressing, Western Blot, Control, Real-time Polymerase Chain Reaction, Polymerase Chain Reaction